Macgest 200mg Injection contains natural micronized progesterone, a key hormone involved in the regulation of the menstrual cycle and maintenance of pregnancy. This injectable formulation delivers 200mg of progesterone per dose, intended for intramuscular administration. Progesterone plays a crucial role in preparing the endometrium for implantation of the fertilized ovum and supports early pregnancy by maintaining the uterine lining. Macgest 200mg Injection is commonly used in assisted reproductive technologies such as in vitro fertilization (IVF) to support the luteal phase and improve pregnancy outcomes. It is also indicated for the treatment of progesterone deficiency states, prevention of threatened miscarriage, and management of certain gynecological disorders related to hormonal imbalance. The natural micronized form ensures better bioavailability and mimics endogenous progesterone activity. Administration should be guided by a healthcare professional, with dosage and duration tailored to the specific clinical scenario. Adverse effects may include injection site reactions, dizziness, headache, and mood changes. Contraindications include known hypersensitivity to progesterone or any component of the formulation, active thrombophlebitis, or thromboembolic disorders. Macgest 200mg Injection should be used with caution in patients with hepatic impairment or cardiovascular disease. Proper storage conditions must be maintained to preserve drug stability and efficacy.